Rene S. Kahn
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Rene S. Kahn has a total of 146 co-authors. Here are the top co-authors by number of shared publications:
- Hilleke E. Hulshoff Pol
Department of Psychiatry, University Medical Center Utrecht, Utrecht, The Netherlands
5 shared publications Michael Davidson
Sheba Medical Center, Tel Hashomer, Israel
4 shared publications- Eske M. Derks
Brain and Mental Health Program, QIMR Berghofer Medical Research Institute, Brisbane, Australia
3 shared publications - Jan Libiger
Psychiatric Clinic, Faculty Hospital Hradec Králové, Charles University Medical School, Hradec Králové, Czech Republic
3 shared publications - Marco Pm Boks
Department of Psychiatry, Amsterdam UMC, Amsterdam, The Netherlands
3 shared publications - Roel A. Ophoff
Center for Neurobehavioral Genetics, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, Los Angeles, USA
3 shared publications
Latest Publications
- 1 June 2019
- Published by Elsevier in Schizophrenia Research
- Vol. 208, 82-89
Longitudinal evidence for a relation between depressive symptoms and quality of life in schizophrenia using structural equation modeling
- 1 June 2019
- Published by Elsevier in Schizophrenia Research
- Vol. 208, 82-89
Longitudinal evidence for a relation between depressive symptoms and quality of life in schizophrenia using structural equation modeling
- 1 March 2018
- Published by Elsevier in Journal of Affective Disorders
- Vol. 229, 141-144
Are infectious agents involved in the pathogenesis of postpartum psychosis?
- 1 March 2018
- Published by Elsevier in Journal of Affective Disorders
- Vol. 229, 141-144
Are infectious agents involved in the pathogenesis of postpartum psychosis?
- 26 October 2017
- Published by Cambridge University Press (CUP) in Psychological Medicine
- Vol. 48 (2) , 247-248
Why the concept of schizophrenia is still alive and kicking
Why the concept of schizophrenia is still alive and kicking - R. S. Kahn
- 26 October 2017
- Published by Cambridge University Press (CUP) in Psychological Medicine
- Vol. 48 (2) , 247-248
Why the concept of schizophrenia is still alive and kicking
Why the concept of schizophrenia is still alive and kicking - R. S. Kahn
- Open Access
A Genetic Population Isolate in The Netherlands Showing Extensive Haplotype Sharing and Long Regions of Homozygosity
Genetic isolated populations have features that may facilitate genetic analyses and can be leveraged to improve power of mapping genes to complex traits. Our aim was to test the extent to which a population with a former history of geographic isolation and religious endogamy, and currently with one of the highest fertility rates in The Netherlands, shows signs of genetic isolation. For this purpose, genome-wide genotype data was collected of 72 unrelated individuals from this population as well as in a sample of 104 random control subjects from The Netherlands. Additional reference data from different populations and population isolates was available through HapMap and the Human Genome Diversity Project. We performed a number of analyses to compare the genetic structure between these populations: we calculated the pairwise genetic distance between populations, examined the extent of identical-by-descent (IBD) sharing and estimated the effective population size. Genetic analysis of this population showed consistent patterns of a population isolate at all levels tested. We confirmed that this population is most closely related to the Dutch control subjects, and detected high levels of IBD sharing and runs of homozygosity at equal or even higher levels than observed in previously described population isolates. The effective population size of this population was estimated to be several orders of magnitude smaller than that of the Dutch control sample. We conclude that the geographic isolation of this population combined with rapid population growth has resulted in a genetic isolate with great potential value for future genetic studies.
Open AccessA Genetic Population Isolate in The Netherlands Showing Extensive Haplotype Sharing and Long Regions of Homozygosity
Genetic isolated populations have features that may facilitate genetic analyses and can be leveraged to improve power of mapping genes to complex traits. Our aim was to test the extent to which a population with a former history of geographic isolation and religious endogamy, and currently with one of the highest fertility rates in The Netherlands, shows signs of genetic isolation. For this purpose, genome-wide genotype data was collected of 72 unrelated individuals from this population as well as in a sample of 104 random control subjects from The Netherlands. Additional reference data from different populations and population isolates was available through HapMap and the Human Genome Diversity Project. We performed a number of analyses to compare the genetic structure between these populations: we calculated the pairwise genetic distance between populations, examined the extent of identical-by-descent (IBD) sharing and estimated the effective population size. Genetic analysis of this population showed consistent patterns of a population isolate at all levels tested. We confirmed that this population is most closely related to the Dutch control subjects, and detected high levels of IBD sharing and runs of homozygosity at equal or even higher levels than observed in previously described population isolates. The effective population size of this population was estimated to be several orders of magnitude smaller than that of the Dutch control sample. We conclude that the geographic isolation of this population combined with rapid population growth has resulted in a genetic isolate with great potential value for future genetic studies.
- Open Access
- 30 August 2016
- Published by Springer Nature in Genome Biology
- Vol. 17 (1) , 1-16
An integrated genetic-epigenetic analysis of schizophrenia: evidence for co-localization of genetic associations and differential DNA methylation
Schizophrenia is a highly heritable, neuropsychiatric disorder characterized by episodic psychosis and altered cognitive function. Despite success in identifying genetic variants associated with schizophrenia, there remains uncertainty about the causal genes involved in disease pathogenesis and how their function is regulated. We performed a multi-stage epigenome-wide association study, quantifying genome-wide patterns of DNA methylation in a total of 1714 individuals from three independent sample cohorts. We have identified multiple differentially methylated positions and regions consistently associated with schizophrenia across the three cohorts; these effects are independent of important confounders such as smoking. We also show that epigenetic variation at multiple loci across the genome contributes to the polygenic nature of schizophrenia. Finally, we show how DNA methylation quantitative trait loci in combination with Bayesian co-localization analyses can be used to annotate extended genomic regions nominated by studies of schizophrenia, and to identify potential regulatory variation causally involved in disease. This study represents the first systematic integrated analysis of genetic and epigenetic variation in schizophrenia, introducing a methodological approach that can be used to inform epigenome-wide association study analyses of other complex traits and diseases. We demonstrate the utility of using a polygenic risk score to identify molecular variation associated with etiological variation, and of using DNA methylation quantitative trait loci to refine the functional and regulatory variation associated with schizophrenia risk variants. Finally, we present strong evidence for the co-localization of genetic associations for schizophrenia and differential DNA methylation.
- 30 August 2016
- Published by Springer Nature in Genome Biology
- Vol. 17 (1) , 1-16
Open AccessAn integrated genetic-epigenetic analysis of schizophrenia: evidence for co-localization of genetic associations and differential DNA methylation
Schizophrenia is a highly heritable, neuropsychiatric disorder characterized by episodic psychosis and altered cognitive function. Despite success in identifying genetic variants associated with schizophrenia, there remains uncertainty about the causal genes involved in disease pathogenesis and how their function is regulated. We performed a multi-stage epigenome-wide association study, quantifying genome-wide patterns of DNA methylation in a total of 1714 individuals from three independent sample cohorts. We have identified multiple differentially methylated positions and regions consistently associated with schizophrenia across the three cohorts; these effects are independent of important confounders such as smoking. We also show that epigenetic variation at multiple loci across the genome contributes to the polygenic nature of schizophrenia. Finally, we show how DNA methylation quantitative trait loci in combination with Bayesian co-localization analyses can be used to annotate extended genomic regions nominated by studies of schizophrenia, and to identify potential regulatory variation causally involved in disease. This study represents the first systematic integrated analysis of genetic and epigenetic variation in schizophrenia, introducing a methodological approach that can be used to inform epigenome-wide association study analyses of other complex traits and diseases. We demonstrate the utility of using a polygenic risk score to identify molecular variation associated with etiological variation, and of using DNA methylation quantitative trait loci to refine the functional and regulatory variation associated with schizophrenia risk variants. Finally, we present strong evidence for the co-localization of genetic associations for schizophrenia and differential DNA methylation.
- 1 April 2016
- Published by Elsevier in Schizophrenia Research
- Vol. 172 (1-3) , 145-151
Predictors of discontinuation of antipsychotic medication and subsequent outcomes in the European First Episode Schizophrenia Trial (EUFEST)
- 1 April 2016
- Published by Elsevier in Schizophrenia Research
- Vol. 172 (1-3) , 145-151
Predictors of discontinuation of antipsychotic medication and subsequent outcomes in the European First Episode Schizophrenia Trial (EUFEST)
- 1 August 2015
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 25 (8) , 1158-1166
Treatment adherence in schizophrenia: A patient-level meta-analysis of combined CATIE and EUFEST studies
- 1 August 2015
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 25 (8) , 1158-1166
Treatment adherence in schizophrenia: A patient-level meta-analysis of combined CATIE and EUFEST studies
- 21 July 2015
- Published by Taylor & Francis in Expert Review of Neurotherapeutics
- Vol. 15 (9) , 969-981
The safety, efficacy and tolerability of Abilify Maintena for the treatment of schizophrenia
Relapse in schizophrenia has been associated with poor adherence to oral medication. A possible method to optimize medication adherence could be to switch patients from oral to depot medication. In...
- 21 July 2015
- Published by Taylor & Francis in Expert Review of Neurotherapeutics
- Vol. 15 (9) , 969-981
The safety, efficacy and tolerability of Abilify Maintena for the treatment of schizophrenia
Relapse in schizophrenia has been associated with poor adherence to oral medication. A possible method to optimize medication adherence could be to switch patients from oral to depot medication. In...
- 1 July 2015
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 25 (7) , 969-1002
Cognitive enhancing agents in schizophrenia and bipolar disorder
- 1 July 2015
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 25 (7) , 969-1002
Cognitive enhancing agents in schizophrenia and bipolar disorder
- Open Access
- 14 September 2014
- Published by Springer Nature in BMC Psychiatry
- Vol. 14 (1) , 244
Delayed school progression and mental health problems in adolescence: a population-based study in 10,803 adolescents
Accumulating evidence suggests that several adult mental disorders, particularly psychoses, are preceded by impairments in cognitive function, reflected in scholastic underachievement. This study investigates the association between scholastic underachievement and general mental health problems in adolescence, using delay in school progression as a marker of poor scholastic performance. Cross-sectional secondary school survey comprising 10,803 adolescents. Participants completed the Strengths and Difficulties Questionnaire (SDQ) to assess mental health problems. The association of delayed school progression with the SDQ was investigated using logistic regression with SDQ as outcome and delayed school progression as primary exposure of interest while adjusting for socio-demographic characteristics, adverse life events, school-related factors, risk taking behaviour, healthy lifestyle and physical health. Unadjusted analysis showed an association between delayed school progression and total mental health problems (OR 1.83, 95% CI 1.27 – 2.63) in adolescents. After adjusting for other risk factors (socio-demographic factors and life events) in a logistic regression model the association between delayed school progression en mental health problems was attenuated (OR 1.33, 95% CI 0.86 – 2.05). Delayed school progression is associated with general mental health problems in adolescence, but this relationship is heavily confounded by other factors. A causal relationship between impaired cognitive function such as poor scholastic performance and general mental health at adolescence is less likely and delayed school progression may merely be considered an indicator of risk for mental health problems.
- 14 September 2014
- Published by Springer Nature in BMC Psychiatry
- Vol. 14 (1) , 244
Open AccessDelayed school progression and mental health problems in adolescence: a population-based study in 10,803 adolescents
Accumulating evidence suggests that several adult mental disorders, particularly psychoses, are preceded by impairments in cognitive function, reflected in scholastic underachievement. This study investigates the association between scholastic underachievement and general mental health problems in adolescence, using delay in school progression as a marker of poor scholastic performance. Cross-sectional secondary school survey comprising 10,803 adolescents. Participants completed the Strengths and Difficulties Questionnaire (SDQ) to assess mental health problems. The association of delayed school progression with the SDQ was investigated using logistic regression with SDQ as outcome and delayed school progression as primary exposure of interest while adjusting for socio-demographic characteristics, adverse life events, school-related factors, risk taking behaviour, healthy lifestyle and physical health. Unadjusted analysis showed an association between delayed school progression and total mental health problems (OR 1.83, 95% CI 1.27 – 2.63) in adolescents. After adjusting for other risk factors (socio-demographic factors and life events) in a logistic regression model the association between delayed school progression en mental health problems was attenuated (OR 1.33, 95% CI 0.86 – 2.05). Delayed school progression is associated with general mental health problems in adolescence, but this relationship is heavily confounded by other factors. A causal relationship between impaired cognitive function such as poor scholastic performance and general mental health at adolescence is less likely and delayed school progression may merely be considered an indicator of risk for mental health problems.